AIDS Therapies

Phase I/II Clinical Trial Of ANTICORT Completed

Published in AIDS Weekly, September 17th, 2001

Samaritan Pharmaceuticals, Inc. announced it has completed its Phase Ib/IIa, dose-escalating clinical human trial for safety, toxicity, and efficacy of Anticort in patients with HIV infection.

This study was conducted under an Investigational New Drug (IND) application filed with the U.S. Food and Drug Administration (FDA).

Dr. Janet Greeson, Samaritan Pharmaceuticals stated, "Achieving this milestone is significant for Samaritan. It is our hope that, after, the Aids Research Alliance (Los Angeles, California) completes the analysis of the data generated by this clinical trial, we'll be able to submit a study report to the FDA by year end (2001) or...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2001-09-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry